Return to Clinical Trials Search Results

A randomized phase III trial comparing an antibody-drug conjugate to Mirvetuximab in patients with FRa high expression and compared to investigators choice chemotherapy in FRa low expression. TREVI-OC-01

Phase

Recruitment Status

View on
ClinicalTrials.gov

Research studies are looking for volunteers just like you. If you have questions or would like to participate, contact our team today.